Please use this identifier to cite or link to this item:
Title: Pilot randomised clinical trial of an eHealth, self-management support intervention (iVERVE) for stroke: feasibility assessment in survivors 12-24 months post-event.
Austin Authors: Cadilhac, Dominique A;Andrew, Nadine E;Busingye, Doreen;Cameron, Jan;Thrift, Amanda G;Purvis, Tara;Li, Jonathan C;Kneebone, Ian;Thijs, Vincent N ;Hackett, Maree L;Lannin, Natasha A;Kilkenny, Monique F
Affiliation: Faculty of Engineering, Monash University, Clayton, VIC, Australia
Department of Neurosciences, Central Clinical School, Monash University, Melbourne, VIC, Australia
Department of Allied Health (Occupational Therapy), Alfred Health, Melbourne, VIC, Australia
Discipline of Clinical Psychology, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia
The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia
Faculty of Health and Wellbeing, The University of Central Lancashire, Preston, UK
Stroke and Ageing Research, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Level 3 Hudson Institute Building, 27-31 Wright Street, Clayton, VIC, 3168, Australia
The Florey Institute of Neuroscience and Mental Health
Department of Medicine, Peninsula Clinical School, Central Clinical School, Monash University, Frankston, VIC, Australia
NPS MedicineWise, Sydney, NSW, Australia
School of Nursing and Midwifery, Monash University, Clayton, VIC, Australia
Medicine (University of Melbourne)
Issue Date: 7-Nov-2020 2020-11-07
Publication information: Pilot and feasibility studies 2020; 6(1): 172
Abstract: Electronic communication is used in various populations to achieve health goals, but evidence in stroke is lacking. We pilot tested the feasibility and potential effectiveness of a novel personalised electronic self-management intervention to support person-centred goal attainment and secondary prevention after stroke. A phase I, prospective, randomised controlled pilot trial (1:1 allocation) with assessor blinding, intention-to-treat analysis, and a process evaluation. Community-based survivors of stroke were recruited from participants in the Australian Stroke Clinical Registry (AuSCR) who had indicated their willingness to be contacted for research studies. Inclusion criteria include 1-2 years following hospital admission for stroke and living within 50 km of Monash University (Melbourne). Person-centred goals were set with facilitation by a clinician using a standardised template. The intervention group received electronic support messages aligned to their goals over 4 weeks. The control group received only 2-3 electronic administrative messages. Primary outcomes were study retention, goal attainment (assessed using Goal Attainment Scaling method) and satisfaction. Secondary outcomes were self-management (Health Education Impact Questionnaire: 8 domains), quality of life, mood and acceptability. Of 340 invitations sent from AuSCR, 73 responded, 68 were eligible and 57 (84%) completed the baseline assessment. At the goal-setting stage, 54/68 (79%) were randomised (median 16 months after stroke): 25 to intervention (median age 69 years; 40% female) and 29 to control (median age 68 years; 38% female). Forty-five (83%) participants completed the outcome follow-up assessment. At follow-up, goal attainment (mean GAS-T score ≥ 50) in the intervention group was achieved for goals related to function, participation and environment (control: environment only). Most intervention participants provided positive feedback and reported that the iVERVE messages were easy to understand (92%) and assisted them in achieving their goals (77%). We found preliminary evidence of non-significant improvements between the groups for most self-management domains (e.g. social integration and support: β coefficient 0.34; 95% CI - 0.14 to 0.83) and several quality-of-life domains in favour of the intervention group. These findings support the need for further randomised effectiveness trials of the iVERVE program to be tested in people with new stroke. ANZCTR, ACTRN12618001519246 . Registered on 11 September 2018-retrospectively registered.
DOI: 10.1186/s40814-020-00706-x
ORCID: 0000-0001-8162-682X
Journal: Pilot and feasibility studies
PubMed URL: 33292693
ISSN: 2055-5784
Type: Journal Article
Subjects: Feasibility studies
Healthcare technology
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Jun 7, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.